Barclays maintains an 'Overweight' on HealthSpring (NYSE: HS), PT $44.

Barclays analyst says, "With that we make the following observations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE